Methotrexate significantly lowers systolic blood pressure in newly diagnosed RA patients compared to sulfasalazine, potentially reducing cardiovascular risk. The study provides prospective comparative ...

Vienna, Austria - Patients with rheumatoid arthritis (RA) who had inadequate response to a first course of methotrexate but have not had major toxicity may be good candidates for a second round of ...

Methotrexate is one of the oldest and most cost-effective medicines available for rheumatoid arthritis (RA). Its also one of the most commonly used RA therapies. Heres what to know about this drug if ...

A 1-year course of methotrexate (MTX) in clinically suspected arthralgia may prevent the development of rheumatoid arthritis (RA) in at-risk individuals who test negative for anti-citrullinated ...

The study analyzed 20 clinical prediction models (CPMs) for rheumatoid arthritis (RA), all of which were deemed to have a high risk of bias, leading the researchers to urge against their use to guide ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — An early, 1-year course of methotrexate may prevent anti-citrullinated protein ...

Methotrexate is a first-line rheumatoid arthritis drug that reduces pain and swelling. It may also slow disease progression and help prevent joint damage. Many people notice less pain, swelling, and ...

Add Yahoo as a preferred source to see more of our stories on Google. Tammi L Shlotzhauer is a distinguished American medic and the author of ‘Living with Rheumatoid Arthritis’ - Barbara Patskin Tammi ...

Rheumatoid Arthritis (RA) is mostly associated with a condition of the joints. Did you know that it can affect your heart ...

Rheumatoid arthritis is a chronic autoimmune condition that affects the joints, causing inflammation, stiffness, and pain. Patients searching for popular rheumatoid arthritis prescriptions are often ...

Rheumatoid arthritis affects the body beyond joint pain — your heart, lungs, skin, vision, bone health, and more. Learn about ...